Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 9/20 | 0.51 |
| ▸ | RUVBL1 | Q9Y265 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TOP2A | P11388 | 2/20 | 0.40 |
| ▸ | TOP2B | Q02880 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23901934 | 0.93 | NISCH (0.49) | NISCHFFAR1FFAR4S1PR1 | |
| SCHEMBL23901784 | 0.88 | NISCH (0.49) | NISCHRUVBL1GAATSHRTOP2A | |
| SCHEMBL23566464 | 0.84 | NISCH (0.58) | NISCHRUVBL1GAATSHRTOP2A | |
| Hydrochloric Acid SCHEMBL23541343 | 0.83 | NISCH (0.57) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL23902206 | 0.82 | F10 (0.40) | NISCHS1PR1 | |
| SCHEMBL23902237 | 0.81 | NISCH (0.51) | NISCHS1PR1 | |
| SCHEMBL23901950 | 0.78 | NISCH (0.54) | NISCHGAATSHRTOP2ATOP2B | |
| Hydrochloric Acid SCHEMBL23880708 | 0.77 | NISCH (0.52) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL23566027 | 0.76 | NISCH (0.56) | NISCH | |
| SCHEMBL23901805 | 0.76 | NISCH (0.65) | NISCHGAATSHRTOP2ATOP2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210309641-A1 | AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-10-07 | — | — | US | disclosed |
| US-9562127-B2 | Methods of forming block polymers for directed self-assembly | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210309641-A1 | AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS | PAM, AMPD1, AMPD3 | NISCH 24/4885RUVBL1 3197/4885GAA 885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.